Fact Meets Function

Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review.

This review article examines the use of growth factors and the stable gastric pentadecapeptide BPC 157 for treating injuries to tendons, ligaments, muscles, and their associated junctions with bone. The authors synthesize evidence from multiple research domains showing that BPC 157 exhibits angiogenic, anti-inflammatory, and tissue-regenerative properties in preclinical models of musculoskeletal injury. The evidence base includes human clinical studies, animal models, and in vitro research, though this is a literature review rather than original research.

Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review. Read Post »

Persistent methaemoglobinaemia due to unsupervised use of topical dapsone-adapalene.

This case report documents a patient who developed persistent methemoglobinemia from unsupervised use of a topical dapsone-adapalene combination product, highlighting the risk of systemic absorption and adverse effects from unmonitored application of this dermatological agent. The patient’s methemoglobinemia was treated with methylene blue, demonstrating its effectiveness in reversing dapsone-induced oxidative damage to hemoglobin. This is a human clinical case report (low evidence level) that illustrates an important safety concern with topical dapsone use.

Persistent methaemoglobinaemia due to unsupervised use of topical dapsone-adapalene. Read Post »

Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins’ activity for fascia regeneration.

This animal study found that GHK-Cu helps repair damaged fascia (connective tissue) by delivering copper to specific parts of cells where it’s needed. The copper activates enzymes that build collagen and promotes blood vessel formation, leading to better tissue healing. In rabbits with fascia injuries, this approach significantly improved tissue repair and regeneration.

Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins’ activity for fascia regeneration. Read Post »

Nicotinamide Mononucleotide Decreases Secretion of Proinflammatory Cytokines via the NAD + /SIRT1/p65 Axis.

This study found that NMN supplementation can reduce inflammation by blocking the release of inflammatory molecules from aging cells. When cells become senescent (aged and damaged), they normally secrete harmful inflammatory substances that contribute to chronic diseases and aging. NMN appears to prevent this inflammatory secretion by boosting cellular energy levels and activating protective proteins. This suggests NMN could help combat age-related inflammation and its associated health problems.

Nicotinamide Mononucleotide Decreases Secretion of Proinflammatory Cytokines via the NAD + /SIRT1/p65 Axis. Read Post »

[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications].

This research review examines how activating estrogen-related receptors (ERRα/β/γ) can mimic the beneficial effects of physical exercise at the molecular level. The study focuses on SLU-PP-332, a compound that targets these receptors to potentially provide exercise-like metabolic benefits for patients who cannot engage in regular physical activity. This pharmacological approach could help address chronic diseases linked to sedentary lifestyles by activating the same cellular pathways that exercise normally triggers. The research suggests promise for treating metabolic dysfunction in physically inactive patients.

[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications]. Read Post »

Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.

This review article examined multiple classes of antiarrhythmic agents—including conventional Class I-IV antiarrhythmics, late sodium current inhibitors, potassium channel enhancers, ryanodine receptor stabilizers, gap junction modulators, atrial-selective agents, and the peptide BPC 157—and their proposed cytoprotective mechanisms in managing cardiac arrhythmias. The authors synthesized evidence suggesting these various drug classes may provide cardioprotection through different cellular pathways, though the review does not present new experimental data comparing efficacy. This is a **review article** synthesizing existing literature rather than original human clinical or experimental research.

Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias. Read Post »

Shopping Cart
Scroll to Top